Results 21 to 30 of about 21,243,142 (99)

Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.

open access: yesJournal of Urology, 2020
PURPOSE A prognostic model for overall survival (OS) of post-platinum patients with metastatic urothelial carcinoma (mUC) receiving PD-1/PD-L1 inhibitors is necessary since existing models were constructed in the chemotherapy setting.
G. Sonpavde   +21 more
semanticscholar   +1 more source

Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma

open access: yesJournal of Cellular and Molecular Medicine, 2020
Hepatocellular carcinoma (HCC) is a heterogeneous malignancy closely related to metabolic reprogramming. We investigated how CTNNB1 mutation regulates the HCC metabolic phenotype and thus affects the prognosis of HCC.
Junyu Huo, Liqun Wu, Yunjin Zang
semanticscholar   +1 more source

A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease

open access: yesAlzheimer's & Dementia, 2020
We developed a prognostic model for overall survival after diagnosis of sporadic Creutzfeldt‐Jakob disease (sCJD) using data from a German surveillance study.
F. Llorens   +7 more
semanticscholar   +1 more source

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma

open access: yesFrontiers in Molecular Biosciences, 2020
Introduction Tumor mutation burden (TMB) is an emerging biomarker for immunotherapy of hepatocellular carcinoma (HCC), but its value for clinical application has not been fully revealed.
Junyu Huo, Liqun Wu, Yunjin Zang
semanticscholar   +1 more source

N6-methyladenosine associated prognostic model in hepatocellular carcinoma

open access: yesAnnals of Translational Medicine, 2020
Background N6-methyladenosine (m6A), the most internal mRNA modification, is involved in various cancers. However, the function of m6A in hepatocellular carcinoma (HCC) is still not well explored.
Hanchun Huang   +5 more
semanticscholar   +1 more source

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model

open access: yesESC Heart Failure, 2020
The aims of this paper were to investigate the analytical performance of the nine prognostic scales commonly used in heart failure (HF), in patients with dilated cardiomyopathy (DCM), and to develop a unique prognostic model tailored to DCM patients.
E. Dziewięcka   +8 more
semanticscholar   +1 more source

A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma

open access: yesInternational Journal of Medical Sciences, 2020
Background: Immune-related genes (IRGs) are critically involved in the tumor microenvironment (TME) of colon adenocarcinoma (COAD). Here, the study was mainly designed to establish a prognostic model of IRGs to predict the survival of COAD patients ...
Yuanlin Sun   +4 more
semanticscholar   +1 more source

Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma

open access: yesBioscience Reports, 2020
Purpose: Stomach adenocarcinoma (STAD) is one of the most common malignant tumors, and its occurrence and prognosis are closely related to inflammation.
Ming Wu   +6 more
semanticscholar   +1 more source

An Innovative Prognostic Model Based on Four Genes in Asian Patient with Gastric Cancer

open access: yesCancer research and treatment : official journal of Korean Cancer Association, 2020
Purpose Gastric cancer (GC) has substantial biological differences between Asian and non-Asian populations, which makes it difficult to have a unified predictive measure for all people. We aimed to identify novel prognostic biomarkers to help predict the
Jiahui Chen   +6 more
semanticscholar   +1 more source

Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation

open access: yesAging, 2020
We systematically developed a prognostic model for pancreatic cancer that was compatible across different transcriptomic platforms and patient cohorts.
Jie Yan   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy